532
Views
5
CrossRef citations to date
0
Altmetric
Original Article

A comparison of tabun-inhibited rat brain acetylcholinesterase reactivation by three oximes (HI-6, obidoxime, and K048) in vivo detected by biochemical and histochemical techniques

, , , , , , , , , & show all
Pages 790-797 | Received 16 Sep 2009, Accepted 22 Oct 2009, Published online: 08 Nov 2010

References

  • Bajgar J. Organophosphates/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis and treatment. Adv Clin Chem 2004;38:151–216.
  • Cabal J, Bajgar J. Tabun – reappearance 50 years later. Chem Listy 1999;93:27–31. [in Czech]
  • Fusek J, Bajgar J, Kassa J, Hajek P, Slizova D, Krs O. Differences in the action of G- and V- agents. In: Bajgar J, ed. Central and Peripheral Nervous System: Effects of Highly Toxic Organophosphates and their Antidotes. Kerala, India: Research Signpost, 2009, in press.
  • Kuca K, Musilek K, Jun D, Bajgar J, Kassa J. Novel oximes. In: Gupta RC, ed. Handbook of Toxicology of Chemical Warfare Agents. Oxford: Elsevier, 2009, 997–1021.
  • Eyer P. The role of oximes in the management of organophosphorus pesticides poisoning. Toxicol Rev 2003;22:165–90.
  • Kassa J, Kuca K, Karasova J, Musilek K, Jun D, Bajgar J, et al. Development of new reactivators of tabun inhibited acetylcholinesterase and the evaluation of their efficacy by in vitro and in vivo methods. Presented at: HFM-149 Symposium on “Defense Against the Effects of Chemical Toxic Hazards: Toxicology, Diagnosis and Medical Countermeasures,” Edinburgh, Scotland, 8–10 October 2007. Session 4, OP Medical Countermeasures, No 17.
  • Marrs TC, Rice P, Vale JA. The role of oximes in the treatment of nerve agent poisoning in civilian casualties. Toxicol Rev 2006;25:297–323.
  • Shih T-M, Skovira JW, O’Donnell JC, McDonough JH. Central cholinesterase reactivation by oximes improves survival and terminates seizures following nerve agent intoxication. Presented at: HFM-149 Symposium on “Defense Against the Effects of Chemical Toxic Hazards: Toxicology, Diagnosis and Medical Countermeasures,” Edinburgh, Scotland, 8–10 October 2007. Session 4, OP Medical Countermeasures, No 18.
  • Berend S, Lucic-Vrdoljak A, Radic B, Kuca K. New bispyridinium oximes: in vitro and in vivo evaluation of their biological efficiency in soman and tabun poisoning. Chem Biol Interact 2008;175:413–16.
  • Pohanka M, Jun D, Kuca K. In vitro reactivation of trichlorfon-inhibited butyrylcholinesterase using obidoxime, pralidoxime and K048. J Enzyme Inhib Med Chem 2009;24:680–3.
  • Kuca K, Cabal J, Jun D, Bajgar J, Hrabinova M. Potency of new structurally different oximes to reactivate cyclosarin-inhibited human brain acetylcholinesterase. J Enzyme Inhib Med Chem 2006;21:663–6.
  • Musilek K, Holas O, Kuca K, Jun D, Dohnal V, Opletalova V, et al. Synthesis of monooxime-monocarbamoyl bispyridinium compounds bearing (E)-but-2-ene linker and evaluation of their reactivation activity against tabun- and paraoxon-inhibited acetylcholinesterase. J Enzyme Inhib Med Chem 2008;23:70–6.
  • Kassa J, Kuca K, Cabal J, Paar M. A comparison of the efficacy of new asymmetric bispyridinium oximes (K027, K048) with currently available oximes against tabun by in vivo methods. J Toxicol Environ Health A 2006;69:1875–82.
  • Kuca K, Kassa J. A comparison of the ability of a new bispyridinium oxime – 1-(4-hydroxyiminomethylpyridinium)-4-(carbamoylpyridinium)butane dibromide and currently used oximes to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods. J Enzyme Inhib Med Chem. 2003;18:529–35.
  • Paxinos G, Watson C. The Rat Brain in Stereotactic Coordinates. New York: Academic Press, 1987.
  • Lojda Z, Gossrau RR, Schiebler TH. Enzyme Histochemistry – A Laboratory Manual. New York: Springer Verlag, 1979.
  • Hammond PI, Jelacic T, Padilla S, Brimijoin S. Quantitative, video-based histochemistry to measure regional effects of anticholinesterase pesticides in rat brain. Anal Biochem 1996;241:82–92.
  • Benali A, Leefken I, Eysel U, Weile E. A computerized image analysis system for quantitative analysis of cells in histological brain sections. J Neurosci Methods 2003;125:33–43.
  • Ellman GL, Courtney DK, Andres V, Featherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88–95.
  • Bajgar J, Hajek P, Slizova D, Krs O, Fusek J, Kuca K, et al. Changes of acetylcholinesterase activity in different brain areas following intoxication with nerve agents: biochemical and histochemical study. Chem Biol Interact 2007;165:14–21.
  • Giacobini G. Cholinesterases in human brain: the effect of cholinesterase inhibitors on Alzheimer’s disease and related disorders. In: Giacobini E,Pepeu G, eds. The Brain Cholinergic System in Health and Disease. Abingdon: Informa Healthcare, 2006:235–64.
  • Gupta RC. Brain regional heterogeneity and toxicological mechanisms of organophosphates and carbamates. Toxicol Mech Methods 2004;14:103–43.
  • Gupta RC, Patterson GT, Dettbarn W-D. Biochemical and histochemical alterations following acute soman intoxication in the rat. Toxicol Appl Pharmacol 1987;87:393–402.
  • Shih T-M, Kan RK, McDonough JH. In vivo cholinesterase inhibitory specificity of organophosphorus nerve agents. Chem Biol Interact 2005;157–8:293–303.
  • Petroianu GA, Nurulain SM, Nagelkerke N, Al-Sultan MAH, Kuca K, Kassa J. Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: survival in rats exposed to the organophosphate paraoxon. J Appl Toxicol 2006;26:262–8.
  • Petroianu GA, Nurulain SM, Nagelkerke N, Shafiullah M, Kassa J, Kuca K. Five oximes (K-27, K-48, obidoxime, HI-6 and trimedoxime) in comparison with pralidoxime: survival in rats exposed to methyl-paraoxon. J Appl Toxicol 2007;27:453–7.
  • Lorke DE, Kalasz H, Petroianu GA, Tekes K. Entry of oximes into the brain: a review. Curr Med Chem 2008;15:743–53.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.